Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Research · July 20, 2022

Progression of Retinopathy With GLP1 Receptor Agonists With Cardiovascular Benefits in Type 2 Diabetes

Journal of Diabetes and its Complications

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Diabetes and its Complications
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis
J Diabetes Complicat 2022 Jul 05;[EPub Ahead of Print], Y Yoshida, P Joshi, S Barri, J Wang, AL Corder, SS O'Connell, VA Fonseca

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading